检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:朱君 魏春霞 王琦 ZHU Jun;WEI Chunxia;WANG Qi(Pediatric Department,Hulunbuir City People's Hospital,Hulunbuir,Inner Mongolia,021008)
机构地区:[1]呼伦贝尔市人民医院儿科,内蒙古呼伦贝尔021008
出 处:《智慧健康》2024年第18期75-77,共3页Smart Healthcare
基 金:呼伦贝尔市科技计划项目《早期鼻塞式持续正压通气治疗小儿重症肺炎的临床研究》(项目编号:SF2021003)。
摘 要:目的探讨早期重症肺炎患儿应用鼻塞式持续气道正压通气(nCPAP)治疗的效果。方法将2019年3月—2020年12月本院收治的30例重症肺炎患儿纳入对照组,实施常规鼻导管吸氧治疗;将2021年1月—2023年6月本院收治的30例重症肺炎患儿纳入观察组,实施早期nCPAP治疗;对比两组的临床疗效、临床体征及PCIS评分、症状缓解时间。结果观察组治疗有效率明显高于对照组(P<0.05);观察组治疗后心率、呼吸频率、PCIS评分均与对照组相当(P>0.05);观察组呼吸困难消失时间、肺部湿啰音消失时间、心率恢复时间均短于对照组(P<0.05)。结论早期重症肺炎患儿应用nCPAP治疗的效果显著,能加快呼吸频率、心率恢复速度,稳定生命体征,可在早期改善病情,具有积极的临床意义。Objective To explore effect of nasal continuous positive airway pressure(nCPAP)in treatment of early severe pneumonia of children.Methods The paper chose 30 children with severe pneumonia in our hospital from March 2019 to December 2020 as control group,treated with routine nasal cannula oxygen therapy,and 30 children with severe pneumonia in our hospital from January 2021 to June 2023 as observation group,with early nCPAP treatment.Clinical effect,clinical signs,PCIS scores,and symptom relief time between two groups were compared.Results Effective rate of treatment in observation group was significantly higher than control group(P<0.05).After treatment,heart rate,respiratory rate,and PCIS scores of observation group were comparable to control group(P>0.05).Observation group had shorter disappearance time of dyspnea,lung moist rales,and recovery time of heart rate than control group(P<0.05).Conclusion nCPAP can achieve significant effect for early severe pneumonia in children,can accelerate recovery rate of respiratory rate and heart rate,stabilize vital signs,improve condition at early stage,which has positive clinical significance.
关 键 词:重症肺炎 早期 鼻塞式持续气道正压通气 治疗效果
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.191.74.140